The 1st transcatheter aortic valve was implanted 10 years ago, laying the foundation for a game-changing technology that has since matured "from an ugly duckling into a beautiful swan," according one researcher.
Replacement Heart Valves
New valves for babies that can grow with them
By Tom Ulrich
TAVI global registry delivers 1st results | MassDevice.com On Call
Updated October 3, 2012, at 9:45 p.m. to correct the lead story.
MASSDEVICE ON CALL — The 1st reports from a global registry evaluating Edwards Lifesciences’ (NYSE:EW) Sapien transcatheter aortic valve implantation inside a failing valve or mitral ring came with mixed results.*
Medtronic lands EU win for smallest CoreValve replacement heart valve
Medical device heavyweight Medtronic (NYSE:MDT) won CE Mark approval in the European Union for a new size of its CoreValve Evolut transcatheter aortic valve implants, the company announced.
The new 23 mm valve, the smallest in the CoreValve suite, allows Medtronic to provide the "broadest range of TAVI patient valve sizes," according to a press release.
Sorin wins new Euro approvals for Perceval heart valve and accessories
Sorin Group (BIT:SRN) touted new European regulatory wins extending use of its Perceval bioprosthetic heart valve and approving a new suite of implantation accessories.
The Perceval valve, which originally won CE Mark last year, was previously limited to patients aged 75 or older. The new indication lowers the age to 65 for patients with aortic valve stenosis or steno-insufficiency.
Medtronic notches milestones in CoreValve TAVI research, adds lower-risk patients
ESC 2012 Roundup: New heart care guidelines, TAVI studies and more
Women vs. men: Gender-based research at ESC 2012
TAVI at ESC 2012: Germans quickly adopt minimally invasive valve replacement
German doctors have adopted transcatheter aortic valve implantation faster than any other country, according to researchers attending the European Society of Cardiology Congress in Munich.
Analyses of the country’s German Aortic Valve Registry suggest that, although about half of all elderly patients are receiving TAVI therapy, doctors are primarily recommending the procedure for high-risk patients, as advised.
Is it time to tame the hype over catheter-based valves? | MassDevice.com On Call
MASSDEVICE ON CALL — Physicians may need to take a step back and temper the hype surrounding transcatheter aortic valve implantation surgeries, researchers warned.
MassDevice.com +3 | The top 3 med-tech stories for August 1, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.